Novanta Beheer

Beheer criteriumcontroles 4/4

De CEO Novanta is Matthijs Glastra, benoemd in Sep2016, heeft een ambtstermijn van 8.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 8.26M, bestaande uit 9.5% salaris en 90.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.37% van de aandelen van het bedrijf, ter waarde $ 23.18M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.6 jaar en 3.5 jaar.

Belangrijke informatie

Matthijs Glastra

Algemeen directeur

US$8.3m

Totale compensatie

Percentage CEO-salaris9.5%
Dienstverband CEO8.2yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn2.6yrs
Gemiddelde ambtstermijn bestuur3.5yrs

Recente managementupdates

Recent updates

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Nov 20
Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Nov 01
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Oct 19
Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Sep 21
Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

Sep 06
Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Aug 19
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Jul 16
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

Jun 06
Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Apr 13
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Mar 29
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

Feb 27
Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Feb 12
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Jan 12
Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Dec 28
We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

Nov 02
Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Oct 03
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Sep 19
With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Aug 23
Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Aug 09

Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Aug 03
Novanta (NASDAQ:NOVT) Could Easily Take On More Debt

Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

Jul 11
Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return

At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?

Jun 09
At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?

Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)

May 10
Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)

Analyse CEO-vergoeding

Hoe is Matthijs Glastra's beloning veranderd ten opzichte van Novanta's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 28 2024n/an/a

US$62m

Mar 29 2024n/an/a

US$69m

Dec 31 2023US$8mUS$784k

US$73m

Sep 29 2023n/an/a

US$76m

Jun 30 2023n/an/a

US$77m

Mar 31 2023n/an/a

US$73m

Dec 31 2022US$7mUS$731k

US$74m

Sep 30 2022n/an/a

US$73m

Jul 01 2022n/an/a

US$64m

Apr 01 2022n/an/a

US$58m

Dec 31 2021US$12mUS$690k

US$50m

Oct 01 2021n/an/a

US$49m

Jul 02 2021n/an/a

US$44m

Apr 02 2021n/an/a

US$44m

Dec 31 2020US$5mUS$625k

US$45m

Oct 02 2020n/an/a

US$41m

Jul 03 2020n/an/a

US$42m

Apr 03 2020n/an/a

US$40m

Dec 31 2019US$4mUS$640k

US$41m

Sep 27 2019n/an/a

US$43m

Jun 28 2019n/an/a

US$56m

Mar 29 2019n/an/a

US$57m

Dec 31 2018US$4mUS$581k

US$51m

Sep 28 2018n/an/a

US$39m

Jun 29 2018n/an/a

US$18m

Mar 30 2018n/an/a

US$12m

Dec 31 2017US$4mUS$511k

US$40m

Compensatie versus markt: De totale vergoeding ($USD 8.26M ) Matthijs } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 8.06M ).

Compensatie versus inkomsten: De vergoeding van Matthijs is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Matthijs Glastra (55 yo)

8.2yrs

Tenure

US$8,262,118

Compensatie

Mr. Matthijs Glastra has been the Chief Executive Officer and Director of Novanta Inc. since September 1, 2016 and serves as its Chairman of the Board since May 13, 2021 and served as its Executive Officer...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Matthijs Glastra
CEO & Chairman of the Board8.2yrsUS$8.26m0.37%
$ 23.2m
Robert Buckley
Chief Financial Officer13.7yrsUS$3.36m0.34%
$ 21.0m
Michele Michele Welsh
General Counsel & Corporate Secretary2.3yrsUS$1.35m0.0041%
$ 257.7k
John Burke
Chief Accounting Officer & Corporate Controllerless than a yeargeen gegevens0.019%
$ 1.2m
Sarah Betadam
Chief Information Officer & Chief Information Security Officer3.8yrsgeen gegevensgeen gegevens
Peter Chang
Advisorless than a yeargeen gegevens0.046%
$ 2.9m
Chuck Ravetto
Group President of Automation Enabling Technologies Group2.6yrsgeen gegevensgeen gegevens
Anna Fain
Senior Vice President of Leadership Development and Diversity1.5yrsgeen gegevensgeen gegevens
Heinrich Dreyer
Group President of Medical Solutions6.6yrsgeen gegevensgeen gegevens

2.6yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van NOVT wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Matthijs Glastra
CEO & Chairman of the Board8.2yrsUS$8.26m0.37%
$ 23.2m
Stephen Bershad
Chairman Emeritus3.5yrsUS$233.48kgeen gegevens
Barbara Hulit
Independent Director2.3yrsUS$247.57k0.0026%
$ 162.0k
Mary Ladone
Directorless than a yeargeen gegevensgeen gegevens
Darlene J. Solomon
Independent Director2.4yrsUS$252.57k0.0028%
$ 173.9k
Lonny Carpenter
Independent Lead Director6.5yrsUS$292.56k0.0092%
$ 576.1k
Frank Wilson
Independent Director3.5yrsUS$277.62k0.0039%
$ 244.6k
Thomas Secor
Independent Director12.4yrsUS$257.57k0.00077%
$ 48.2k
Robert Johnson
Independent Directorless than a yeargeen gegevens0%
$ 0
Maxine Mauricio
Independent Director4.5yrsUS$257.56k0.0056%
$ 349.7k

3.5yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van NOVT wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).